THOMAS J. MINER, MD

Plain English
This study looked at how effective video feedback is for teaching surgical residents the skills needed for connecting blood vessels in a procedure called vascular anastomosis. Over three years, 31 surgical residents improved their self-assessed skills from an average score of 29.1 to 46.6 after training, while faculty scored them higher too, increasing from 29.6 to 49.9. This matters because it shows that video analysis not only helps residents learn better but also reduces gender bias in evaluations, which could lead to fairer assessments in their training. Who this helps: This benefits surgical residents, especially women in training.

Plain English
This study examined how age affects the use of opioids after knee replacement surgery in 506 patients. It found that younger patients (ages 40-59) were more likely to use opioids longer and had higher total opioid consumption compared to older patients, with a significant decrease in persistent opioid use as age increased. For instance, younger patients had a higher rate of ongoing opioid prescriptions three months post-surgery and used more opioids on average during that time. Who this helps: This research benefits patients and doctors by highlighting the need to manage pain effectively, especially for younger patients after surgery.

Plain English
This study looked at whether asking surgical interns reflective questions every two weeks could improve their well-being during their training. Over two years, 13 interns responded to prompts about their experiences and feelings related to their work. The findings showed that this approach is valuable for enhancing intern wellness, and most interns engaged positively, which can help prevent burnout in this challenging profession. Who this helps: This benefits medical interns and residency programs.

Plain English
This study looked at whether the number of medication mistakes made by general surgery residents could indicate how well they are performing. Over four years, 95 residents placed over a million medication orders, resulting in 1,214 errors, which is about 0.1% of all orders. While the error rate dropped as residents advanced in their training, it didn't consistently match up with their performance scores, suggesting that mistakes in ordering medications might reveal issues not captured by current testing methods. Who this helps: This helps medical educators identify residents who may need extra support.

Plain English
This study focused on different surgical methods for treating a type of skin cancer called malignant melanoma in-situ (labeled as lentigo maligna). It found that there are various recommended surgical techniques, including wide local excision and Mohs surgery, but the terms used to describe them can be unclear. Clarifying these terms is important so that doctors can follow guidelines properly and provide the best care for patients. Who this helps: This helps patients with skin cancer and the doctors treating them.

Plain English
This research looked at the careers of surgical trainees who won awards from the New England Surgical Society over 32 years. They found that 71.4% of these winners are now working as full doctors in various surgical specialties, and 87.6% of their research was published. This shows that attending these regional conferences not only supports high-quality research but also helps build lasting professional connections among surgeons. Who this helps: This benefits surgical trainees, medical educators, and healthcare institutions.

Plain English
This study looked at how medical students and faculty perceive and benefit from Morbidity and Mortality (M&M) conferences, which aim to improve surgical quality and education. Researchers found that faculty considered more errors to be the fault of the practitioner (57.6%) compared to medical students (27.6%). Additionally, faculty rated the conference as more useful for their education (4.24 out of 5) compared to students (3.71). These findings suggest that more changes are needed to improve the learning experience for medical students at these conferences. Who this helps: This helps medical students and educators in surgical training.

Plain English
This study explored a specialized first aid course designed for commercial fishermen, focusing on the unique dangers of their work. The course, called Fishermen First Aid and Safety Training (FFAST), lasted two days and was well-received by participants, who showed improved knowledge and skills after completing it. This training is vital because commercial fishing is a risky job, and better emergency care can save lives. Who this helps: This benefits commercial fishermen and their families by improving safety and emergency response on the job.

Plain English
This study compared two types of rehabilitation programs after knee replacement surgery: a high-intensity program that started four days post-surgery and a low-intensity program. Researchers found that while both groups experienced improvements in strength and function after 12 months, there were no significant differences between the two approaches. This means that both high and low-intensity rehab programs are safe and effective for recovery after surgery. Who this helps: This benefits patients recovering from total knee arthroplasty.

Plain English
The researchers studied a new treatment for advanced pancreatic cancer that replaces one of the drugs in a common regimen with nab-paclitaxel. They found that patients could safely receive nab-paclitaxel at a dose of 150 mg/m every two weeks alongside other medications, with 60% of patients showing a partial response to the treatment. Patients with metastatic pancreatic cancer had a median survival of 15 months, indicating that this new approach could be an effective option for those facing this aggressive disease. Who this helps: This benefits patients diagnosed with advanced pancreatic cancer.

Plain English
This study looked at the use of a drug called lenalidomide for patients with advanced liver cancer (hepatocellular cancer) who had previously been treated with another drug, sorafenib. Out of 40 patients, 6 (15%) showed a significant improvement in their condition, and 2 patients remained stable for over 2 years. The average time patients lived without their cancer worsening was about 3.6 months, and the average overall survival was 7.6 months. Who this helps: This information benefits patients with advanced liver cancer and their doctors by providing new treatment options.

Plain English
This study looked at what factors might predict whether patients would take longer than three days to regain their independence after knee replacement surgery. Out of 193 patients, 39% (76 individuals) experienced delays in recovery. Key findings showed that older age, being female, and having a higher body mass index (BMI) are significant risk factors for slower recovery, while factors like blood loss and surgical technique had little impact. Who this helps: This helps patients undergoing knee replacement surgery and their care teams.

Plain English
This study focused on how to improve the care of patients with gastric cancer. An expert panel identified 22 guidelines, which included key practices such as using CT scans before surgery, ensuring surgeons have experience with gastric cancer, and recommending a team-based decision-making approach. These guidelines aim to enhance the treatment and management of gastric cancer, ultimately leading to better patient outcomes. Who this helps: This benefits gastric cancer patients and their healthcare providers.

Plain English
This study examined the best ways to treat gastric cancer by gathering opinions from 16 experts around the world. They assessed 416 different treatment scenarios and found that surgery alone is appropriate for early-stage patients but unclear for slightly more advanced cases. For patients with advanced disease, a combination of surgery and chemotherapy is often needed, while certain treatments are not recommended for patients without severe symptoms. Who this helps: This research benefits doctors and patients fighting gastric cancer by guiding treatment decisions.

Plain English
This study looked at patients with advanced cancer who were receiving palliative surgical consultations to understand their symptoms and treatment outcomes. Out of 202 patients, those who had surgery saw the highest rates of symptom improvement at 78%, compared to 60% for non-operative treatments and 69% for procedures. This research shows that improving symptoms can lead to better survival rates, highlighting the importance of surgical options in managing advanced cancer. Who this helps: This helps patients with advanced cancer and their doctors by providing valuable insights into effective treatment options.

Plain English
This study looked at how to better manage hereditary diffuse gastric cancer (HDGC), which is a rare type of stomach cancer. A panel of 16 doctors reviewed 47 different situations regarding genetic testing and preventive surgery, scoring how appropriate each situation was. They found that patients with a family history of diffuse gastric cancer or certain types of breast cancer should get genetic testing, and those who test positive should be offered surgery after age 20 to reduce their cancer risk. Who this helps: This benefits patients with a family history of gastric cancer and their healthcare providers.

Plain English
This study examined the minimum number of gastric cancer surgeries that surgeons and hospitals should perform to ensure patient safety and positive outcomes. The expert panel determined that surgeons should handle at least 11 cases per year for certain procedures, and hospitals should manage at least 21 cases annually for any gastric cancer operation to be considered appropriate. These findings are important because they help set clear guidelines for the care of patients with gastric cancer, ensuring they receive surgery from experienced providers. Who this helps: This helps patients with gastric cancer by ensuring they have access to skilled surgeons and capable hospitals.

Plain English
This study looked at how well lapatinib and gemcitabine could help patients with advanced pancreatic cancer. The researchers aimed for 30% of patients to survive for a year and a median survival of 7 months, but they found that only 10% of patients responded to the treatment, with a median survival of just 4 months. These results indicate that lapatinib is not an effective treatment for pancreatic cancer, suggesting that similar drugs shouldn't be explored further in this type of cancer. Who this helps: This information is valuable for doctors deciding on treatment options for pancreatic cancer patients.

Plain English
This study looked at gene mutations in patients with a type of leukemia called acute myeloid leukemia (AML). Researchers found that over 30% of patients had known mutations in specific genes, but they also identified 4 new mutations in a small number of patients and discovered variations in 14 other genes that are not well understood. This research is important because understanding these genetic changes could lead to better treatments for leukemia. Who this helps: This helps patients with acute myeloid leukemia and their doctors.

Plain English
This study looked at the safety and effectiveness of a drug called lapatinib combined with gemcitabine (and later with oxaliplatin) for patients with advanced pancreaticobiliary cancer. They found that while patients could tolerate the higher dose of 1500 mg of lapatinib with gemcitabine, the maximum safe dose was 1000 mg when combined with oxaliplatin. Overall, patients had a median survival of 11 months, with 48% surviving for at least a year. Who this helps: This benefits patients with advanced pancreaticobiliary cancer.

Plain English
This study focused on acute myeloid leukaemia (AML), a severe type of blood cancer affecting about 13,000 adults in the U.S. each year. Researchers used DNA sequencing to examine both the cancer cells and healthy cells from the same patient, identifying ten important genetic mutations linked to the disease—two of which were already known, and eight that were newly discovered. These findings are significant because they pave the way for new treatments that target these mutations more effectively. Who this helps: Patients with acute myeloid leukaemia and their doctors.

Plain English
This study looked at how long patients with liver cancer (hepatocellular carcinoma) had to wait for a liver transplant and how that affected their chances of survival. Out of 63 patients who joined the transplant list, 41 received a transplant, and 85% of those were alive three years later. However, the researchers found that those who were removed from the waiting list—whether due to dying or becoming too sick—had a 10-20% lower chance of survival than those who actually received a transplant. Who this helps: This information benefits patients with liver cancer and their doctors by highlighting the importance of timely liver transplants.

Plain English
This study looked at new treatments for pancreatic cancer that target the HER family of receptors, which are involved in cancer growth. The researchers found that using erlotinib, a drug targeting HER1, can help patients with advanced pancreatic cancer live longer, but many other drugs in this category are still being tested. This is important because improving treatment options can lead to better outcomes for patients suffering from this difficult-to-treat cancer. Who this helps: Patients with pancreatic cancer and their doctors.

Plain English
This study looked at the genetic changes in patients with severe congenital neutropenia (SCN) who later developed acute leukemia (AML) compared to those with AML that started without prior health issues. Researchers found that in 14 leukemia samples from SCN patients, mutations in the CSF3R gene were common, while the usual mutations in other genes like FLT3, KIT, and JAK2 were not present. This matters because it highlights a different mutation pattern in SCN patients, which could lead to new ways of understanding and treating leukemia. Who this helps: This helps patients with severe congenital neutropenia and their doctors.

Plain English
This study looked at the challenges faced by researchers trying to improve care for patients with malignant bowel obstruction (MBO). It found that researchers struggle with issues like a lack of funding, difficulty finding eligible patients, and various ethical concerns about designing and conducting clinical trials. This matters because improving the management of MBO can significantly impact patient care and outcomes. Who this helps: Patients with malignant bowel obstruction.

Plain English
In this study, researchers tested a combination of three chemotherapy drugs—docetaxel, oxaliplatin, and capecitabine—in patients with advanced esophageal and gastric cancers to find the highest safe doses to use. They found that a specific combination of doses (docetaxel at 30 mg/m2, oxaliplatin at 50 mg/m2, and capecitabine at 750 mg/m2 taken twice daily) is manageable and can be effectively used in treatment cycles every three weeks. This matters because it offers a new treatment option that could improve outcomes for patients with these difficult-to-treat cancers. Who this helps: People with metastatic esophageal and gastric cancer.

Plain English
This study looked at how well a combination of three chemotherapy drugs—docetaxel, carboplatin, and capecitabine—works in treating patients with advanced esophageal or gastric cancer. Out of 25 patients treated, 12 experienced significant side effects, but 48% showed a positive response to the treatment, either fully or partially. Patients survived an average of 8 months, with 36% living for at least one year, showing that this simpler treatment option can be effective compared to more complicated ones. Who this helps: This benefits patients with metastatic esophagogastric cancer.

Plain English
This study looked at how much of the drug paclitaxel poliglumex (PPX) patients with esophageal and gastric cancer can tolerate when given alongside radiation therapy. Researchers found that the highest safe dose was 70 mg per square meter of body surface area, and 33% of patients receiving treatment for localized cancer showed complete clinical improvement. This matters because it helps determine effective treatment options that could lead to better outcomes for cancer patients. Who this helps: This helps patients with esophageal and gastric cancer.

Plain English
This study explored a combination of three chemotherapy drugs—docetaxel, capecitabine, and carboplatin—to find the highest safe doses for treating patients with advanced esophageal and gastric cancers. Among the 28 patients treated, 40% saw their cancer shrink, and this number increased to 57% at the highest dose level. The research highlights the potential of this drug combination to effectively treat these cancers, though some patients experienced side effects like nausea and low blood cell counts. Who this helps: This benefits patients with metastatic esophageal and gastric cancers.

Plain English
This study focused on finding the highest safe dose of a drug called erlotinib used alongside chemotherapy and radiation for patients with locally advanced pancreatic cancer. The researchers found that the maximum tolerated dose for erlotinib was 50 mg per day, and after treatment, patients had a median survival of 14 months, with nearly half of them showing improvement in their condition. These findings matter because they help establish a treatment plan that could potentially extend life for patients struggling with this aggressive form of cancer. Who this helps: This research benefits patients with locally advanced pancreatic cancer and their doctors.

Plain English
This study looked at the genomes of two types of bacteria, Paratyphi A and Typhi, which only infect humans and cause typhoid fever. Researchers found that while both bacteria have similar genomes, Paratyphi A has around 173 inactive genes (pseudogenes), and Typhi has about 210. This matters because understanding their genetic differences can help researchers figure out how these bacteria work and develop better treatments for typhoid fever. Who this helps: This helps patients with typhoid fever and healthcare providers treating them.

Plain English
This study looked at the male-specific part of the Y chromosome, which makes up 95% of its length. Researchers found it to be a mix of different sequence types, with 156 active gene areas that produce 27 unique proteins. Notably, some sequences are almost identical to those on the X chromosome, while others are remnants of ancient genes, which shows how the Y chromosome has changed over time. This finding matters because it helps us understand male biology and could inform research on related health issues. Who this helps: This helps researchers studying male genetics and related health conditions.

Plain English
This study explored the DNA of different yeast species to find important gene-regulating elements and other functional parts of their DNA. Researchers focused on Saccharomyces yeasts, particularly to see which ones would provide the best comparisons with the common baker's yeast, *S. cerevisiae*. They found that looking at closely related yeast species helps identify vital DNA sequences that play important roles, making it easier to understand how these yeasts function. Who this helps: This helps researchers working with yeast in areas like baking and brewing, as well as those studying genetics.

Plain English
This research examined the genetic makeup of the cystic fibrosis transmembrane conductance regulator (CFTR) gene in humans and mice. The study successfully sequenced around 189,000 base pairs from the human CFTR gene and about 152,000 base pairs from the mouse Cftr gene, uncovering important regions that may control how these genes are expressed. These findings enhance our understanding of how CFTR functions and might lead to better treatments for cystic fibrosis in the future. Who this helps: Patients with cystic fibrosis and genetic researchers.

Plain English
This study looked at how well a treatment called external fixation worked for kids with broken thigh bones (femurs). Out of 37 fractures in 33 children, 36 healed successfully, but 8 kids had their bones break again after treatment, which is a rate of 21.6%. This is important because it shows that while this treatment can help heal fractures, the chance of re-breaking is higher than previously thought, especially for kids with fractures in both legs. Who this helps: This information helps doctors and parents understand the risks associated with treating femur fractures in children.

Plain English
This study looked at how the order in which tasks are presented and factors like speed of thinking and control over distractions affect performance on a test called the Trail Making Test (TMT). In a group of 110 college students, the researchers found that the order in which the test parts were given mattered, but how fast the students thought or how well they controlled distractions did not change their scores. This finding highlights that when using the TMT, it's important to be mindful of the order of the test parts to get accurate results. Who this helps: This helps clinicians and researchers assessing cognitive function in patients.

Plain English
Researchers studied how a specific mutant of a bacteria called Salmonella typhimurium (named ilvA504) affects the production of certain proteins involved in making branched-chain amino acids. They found that when they added a specific compound (pyridoxal-5'-monophosphate) to the mutant's environment, the bacteria grew faster and made fewer proteins needed for synthesizing isoleucine and valine. However, the overall production rates of the proteins they were measuring remained the same when comparing the mutant to the normal strain of the bacteria. Who this helps: This research benefits scientists studying bacterial growth and metabolism, which can inform treatments for bacterial infections.